Non-inferiority testing for qualitative microbiological methods:Assessing and improving the approach in USP <1223>

2Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The United States Pharmacopoeia (USP) presents two approaches for showing non-inferiority of an alternate qualitative microbiological method versus a compendial method. One approach compares the positive rates for the alternate and compendial methods at one spike level, while the other one compares multiple most probable number (MPN) estimates from a multi-spike design using a t-test. In this paper, we discuss these approaches under certain assumptions and propose a third approach that can be used for both single and multiple dilutions, which we call the generalized MPN (gMPN) approach. Simulations, using Poisson distributed numbers of microorganisms in test samples, confirm that the USP approach based on rates is not suitable, that the USP approach based on MPNs is appropriate for non-inferiority, but the gMPN approach outperforms the MPN-based approach and is therefore recommended.

Cite

CITATION STYLE

APA

IJzerman-Boon, P. C., Manju, M. A., & van den Heuvel, E. R. (2022). Non-inferiority testing for qualitative microbiological methods:Assessing and improving the approach in USP <1223>. Journal of Biopharmaceutical Statistics, 32(6), 915–941. https://doi.org/10.1080/10543406.2022.2065498

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free